Searched for
SIGNIFICANT SYMPTOMATIC IMPROVEMENT
Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...- Suspected hantavirus outbreak on Atlantic cruise ship leaves 3 dead, WHO confirms: What is it and how does it spread?A suspected hantavirus outbreak on the MV Hondius cruise ship has resulted in three deaths and several illnesses, with one patient in inten...
- Going online helps Pakistan's women doctors back to workThousands of Pakistani women doctors are returning to practice through telemedicine. This initiative connects home-based doctors with patie...
- ‘Cicada’ Covid variant with 75 mutations is spreading: What it means for youCicada Covid Variant Symptoms: A new COVID variant with 70-75 spike protein mutations has been detected. The new virus can potentially evad...
- Eli Lilly get nod from CDSCO for it Alzheimer’s drug DonanemabEli Lilly has secured marketing authorization from India's CDSCO for its Alzheimer's drug, donanemab. This new disease-modifying therapy ta...
- Boost kidney function naturally: Top fruits that fight inflammation and protect renal healthCertain fruits, including blueberries, cranberries, apples, red grapes, and pomegranates, offer significant benefits for kidney health. The...
- Lupin inks pact with Celnova Pharma for distribution of drug in 2 South American nationsLupin's subsidiary has signed a pact with Celnova Pharma to distribute NaMuscla in Argentina and Colombia. The drug treats non-dystrophic m...
- Lupin enters pact with Medis to distribute orphan drug in EuropeNDM disorders are a group of rare, inherited neuromuscular disorders which is characterized by the inability to relax muscles following vol...
- Optimus Pharma to launch COVID-19 drug Molnupiravir shortlyThe firm has developed the API (active pharmaceutical ingredient) in house at its R&D centre here. Optimus Pharma has revealed highly promi...
- Lower risk of hospital admission from Omicron, UK saysUK Health Security Agency said evidence showed protection against symptomatic disease waned after the second dose of a COVID-19 vaccine, an...
- Two doses of Covid vaccines induce lower antibody levels against Omicron: Oxford studyTwo doses of Pfizer and AstraZeneca COVID-19 vaccines generate lower levels of antibodies against the Omicron variant of coronavirus, accor...
- Rajnath Singh to release first batch of DRDO's 2DG medicine for treating COVID-19 patients todayThe first batch of 10,000 doses of 2DG medicine would be launched early next week, informed Defence Research and Development Organisation o...
- DRDO’s new oral drug to reduce dependence on oxygenThe Institute of Nuclear Medicine and Allied Sciences, a DRDO lab, worked in partnership with Dr Reddy’s Laboratories to develop the drug, ...
- Govt issues updated clinical guidance for management of COVID-19 patientsThe guidelines issued by AIIMS, ICMR-COVID-19 National Task Force and the Joint Monitoring Group (DGHS) under the ministry stated that toci...
- Household savings sequentially contract to pre-COVID levels: RBI reportPreliminary estimates show household financial savings rate sequentially fell to to 10.4 per cent of GDP in Q2'2020-21 from the high of 21....
- 'Real-world' UK data shows 70% decline in COVID infections after first Pfizer shotData analysed by Public Health England (PHE) showed the Pfizer provided high levels of protection against infection and symptomatic disease...
- Coronavirus may deplete testosterone levels, and men can experience 'loss of libido'Low testosterone levels could be a cause for poor prognosis following a positive test for the virus.
- Lupin inks distribution pact with 3 firms to commercialise NaMuscla in EuropeExeltis Healthcare SL, Cresco Pharma BV and Macure Pharma ApS will commercialise NaMuscla for the symptomatic treatment of myotonia in adul...
- At 0.2%, June core growth hits 50-month lowData reflects economic slowdown and lack of pickup in investment.
- New malaria vaccine generates robust immune responseA new malaria vaccine candidate has been found to generate robust immune response while significantly delaying parasitemia in 59 per cent o...
Load More
